These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27596142)

  • 1. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
    Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
    Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
    Feng Y; Gao Y; Yu J; Jiang G; Zhang X; Lin X; Han Q; Rong X; Xu H; Li Q; Qiu X; Wang E
    Mol Carcinog; 2019 Jan; 58(1):126-134. PubMed ID: 30242906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
    Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
    Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.
    Lin G; Sun L; Wang R; Guo Y; Xie C
    J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
    Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
    Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
    Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
    Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer.
    Gu J; Chen J; Feng J; Liu Y; Xue Q; Mao G; Gai L; Lu X; Zhang R; Cheng J; Hu Y; Shao M; Shen H; Huang J
    Tumour Biol; 2016 Jul; 37(7):8681-9. PubMed ID: 26738863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X; Han S; Zhou H; Cai L; Li J; Liu N; Liu Y; Wang L; Fan C; Li A; Miao Y
    Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.
    Zhang X; Ke X; Pu Q; Yuan Y; Yang W; Luo X; Jiang Q; Hu X; Gong Y; Tang K; Su X; Liu L; Zhu W; Wei Y
    Oncotarget; 2016 Mar; 7(12):14569-85. PubMed ID: 26910912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
    Zhang Y; Ma M; Han B
    Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
    J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.